A new discovery about the lungs of premature babies – which could improve the way neonatal patients are treated – has been made as part of a Christchurch research collaboration.
How do you help someone suffering fatigue after a traumatic brain injury? You start by designing a product or service around them, rather than for them, and you include those with “lived experience” in that process. This is how the Burwood Academy of Independent Living works.
New Zealand needs three things to continue the growth momentum for our health-tech sector and Molly Yang, an experienced health-tech investment manager, shares her view with us.
An innovative drug verification analyser developed by private company Veriphi is being trialled on five oncology drugs at the University of Auckland’s School of Pharmacy. The goal is to reduce injury, isolate problem areas and create greater transparency for IV medication delivery.
An Auckland-based company hopes to launch a new AI-augmented eye examination tool by the end of 2021 to improve the speed and accuracy of detecting a range of diseases from diabetes to macular degeneration.
There’s a lot happening with medical imaging at Gisborne’s Mātai research centre, headed by Dr Samantha Holdsworth – from brain injury and cardiovascular disease to child wellbeing scans.
This is how Bruce Stokes describes himself, but the truth is that his “tinkering” has led to two spinout companies in two years, one of them a response to COVID-19.
Wellington-based medtech company Volpara Health Technologies breast imaging tools are being used around the world to assist the early detection of breast cancers.
A group of New Zealanders believe they've invented a solution to stop people from touching their face to stop the spread of Covid-19.
University of Auckland spinout Elbaware seeks investment to bring FaceHAP to market.